Tuberculosis Multidrug-resistant

• CLINICAL_TRIALS trial_result · 2025-08-12
  Clinical Trial Update: Linezolid Dosing Strategies in Drug-Resistant TB [Phase 2]

  A Phase 2 clinical trial is evaluating linezolid dosing strategies for drug-resistant tuberculosis. The study is currently listed as ACTIVE_…

• CLINICAL_TRIALS trial_result · 2025-02-10
  Clinical Trial Update: Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q) [Phase 3]

  Phase 3 endTB-Q trial evaluating regimens with newly approved drugs for multidrug-resistant tuberculosis with fluoroquinolone resistance has…

• CLINICAL_TRIALS trial_result · 2024-05-01
  Clinical Trial Update: Pragmatic Clinical Trial for a More Effective Concise and Less Toxic MDR-TB Treatment Regimen(s) [Phase 2, Phase 3]

  This document reports an update on a pragmatic Phase 2/3 trial evaluating a more effective, concise, and less toxic regimen for multidrug-re…

• CLINICAL_TRIALS trial_result · 2023-09-01
  Clinical Trial Update: The Individualized M(X) Drug-resistant TB Treatment Strategy Study [Phase 4]

  Phase 4 trial update for an individualized M(X) drug-resistant TB treatment strategy; the study is terminated.

• CLINICAL_TRIALS trial_result · 2023-05-24
  Clinical Trial Update: Efficacy and Safety of Levofloxacin for the Treatment of MDR-TB [Phase 2]

  Phase 2 clinical trial evaluating the efficacy and safety of levofloxacin for treating multidrug-resistant tuberculosis has completed with p…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2023-03-29
  Clinical Trial Update: Preventing Acquired Resistance: Strengthen TB Treatment by Adding Amikacin in the First Treatment Week of Multidrug-resistant Tuberculosis [Phase 2]

  Phase 2 trial updating TB treatment by adding amikacin during the first treatment week to prevent acquired resistance in multidrug-resistant…

• CLINICAL_TRIALS trial_result · 2023-01-18
  Clinical Trial Update: A Study of an Oral Short-course Regimen Including Bedaquiline for the Treatment of Participants With Multidrug-resistant Tuberculosis in China [Phase 4]

  A Phase 4 trial update evaluating an oral short-course regimen that includes bedaquiline for multidrug-resistant tuberculosis in China.

• CLINICAL_TRIALS trial_result · 2021-12-01
  Clinical Trial Update: A Trial to Evaluate OPC 67683 in Participants With Pulmonary Sputum Culture-positive, Multidrug-resistant Tuberculosis (TB) [Phase 2]

  Phase 2 trial update for OPC 67683 in pulmonary sputum culture-positive, multidrug-resistant tuberculosis (TB) has completed with results po…